NCT07607262 RIPB Versus EOIPB for Pain Control After Laparoscopic Cholecystectomy
| NCT ID | NCT07607262 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital |
| Condition | Laparoscopic Cholecystectomy |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-05-15 |
| Primary Completion | 2026-06-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2026-05-15 with a primary completion date of 2026-06-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study aims to compare the effects of bilateral ultrasound-guided recto-intercostal plane block(RIPB) and bilateral ultrasound-guided external oblique intercostal plane block(EOIPB) on postoperative analgesia in patients undergoing elective laparoscopic cholecystectomy under general anesthesia. Both blocks are performed after anesthesia induction as part of routine preemptive multimodal analgesia practice. Patients who receive bilateral recto-intercostal plane block will be included in the RIPB group, and patients who receive bilateral external oblique intercostal plane block will be included in the EOIPB group. The primary outcome is cumulative intravenous tramadol consumption via patient-controlled analgesia during the first 24 postoperative hours. Secondary outcomes include postoperative pain scores at rest and during activity, rescue analgesic requirement, postoperative nausea and vomiting, time to mobilization, length of hospital stay, quality of recovery assessed using the Quality of Recovery-15 questionnaire, and block-related complications.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 75 years * American Society of Anesthesiologists (ASA) physical status I-III * Scheduled for elective laparoscopic cholecystectomy under general anesthesia * Written informed consent obtained Exclusion Criteria: * Refusal to participate * Inability to understand the study protocol or provide informed consent * Known allergy to local anesthetics, tramadol, paracetamol, dexketoprofen, or other study drugs * Chronic opioid or steroid use * Psychiatric or cognitive disorder preventing reliable pain assessment * Inability to use patient-controlled analgesia * Pregnancy or breastfeeding * Coagulopathy * Infection at the block site * Difficult or prolonged intubation requiring three or more attempts * Conversion to open surgery * Surgery lasting longer than 120 minutes * Intraoperative or postoperative complications requiring deviation from the standard analgesia protocol
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07607262 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Laparoscopic Cholecystectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07607262 currently recruiting?
Yes, NCT07607262 is actively recruiting participants. Contact the research team at berfinozelsel@gmail.com for enrollment information.
Where is the NCT07607262 trial being conducted?
This trial is being conducted at Sancaktepe, Turkey (Türkiye).
Who is sponsoring the NCT07607262 clinical trial?
NCT07607262 is sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. The trial plans to enroll 60 participants.